Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel With MORAb-004 in Metastatic Soft Tissue Sarcoma

NCT01574716 is registered in ClinicalTrials.gov with Morphotek as lead sponsor.

NCT NCT01574716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01574716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel With MORAb-004 in Metastatic Soft Tissue Sarcoma
Lead sponsor
Morphotek
Phase
Phase 2
Overall status
Completed
Start date
August 7, 2012
Completion date
August 2, 2016
Enrollment
209 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic soft tissue sarcoma